Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shohei Udagawa"'
Autor:
Akihiro Ohmoto, Kenji Nakano, Naoki Fukuda, Xiaofei Wang, Tetsuya Urasaki, Naomi Hayashi, Hirotaka Suto, Shohei Udagawa, Ryosuke Oki, Yasuyoshi Sato, Mayu Yunokawa, Makiko Ono, Masanori Saito, Yusuke Minami, Keiko Hayakawa, Taisuke Tanizawa, Keisuke Ae, Seiichi Matsumoto, Junichi Tomomatsu, Shunji Takahashi
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Trabectedin is a therapeutic option for patients with advanced sarcoma. While a randomized trial demonstrated its prolonged progression-free survival (PFS), the reported PFS was 1 year). The ORR in the 49 evaluable patients was 8%, and the median PFS
Externí odkaz:
https://doaj.org/article/1ad98d3f83ec4a80b58fa31dacaacb84
Autor:
Akiyoshi Kasuga, Takeshi Okamoto, Shohei Udagawa, Chinatsu Mori, Takafumi Mie, Takaaki Furukawa, Yuto Yamada, Tsuyoshi Takeda, Masato Matsuyama, Takashi Sasaki, Masato Ozaka, Arisa Ueki, Naoki Sasahira
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 3, p 1205 (2022)
Hereditary pancreatic cancers are caused by several inherited genes. Familial pancreatic cancer is defined as pancreatic cancer arising in a patient with at least two first-degree relatives with pancreatic cancer in the absence of an identified genet
Externí odkaz:
https://doaj.org/article/795b861fa4d3491da3f893513f26c049
Autor:
Akiyoshi Kasuga, Masanori Nojima, Takeshi Okamoto, Takahiro Ishitsuka, Manabu Yamada, Hiroki Nakagawa, Shohei Udagawa, Chinatsu Mori, Takafumi Mie, Takaaki Furukawa, Yuto Yamada, Tsuyoshi Takeda, Masato Matsuyama, Takashi Sasaki, Masato Ozaka, Naoki Sasahira
Publikováno v:
Internal Medicine. 61:3641-3649
Objective The coronavirus disease (COVID-19) pandemic has altered the delivery of medical care. The present study evaluated the impact of COVID-19 on the outcomes of unresectable pancreatic cancer (PC) patients who received end-of-life care. Methods
Autor:
Naoki Fukuda, Kazuhisa Toda, Shohei Udagawa, Akihiro Ohmoto, Ryosuke Oki, Hirotaka Suto, Xiaofei Wang, Naomi Hayashi, Tetsuya Urasaki, Yasuyoshi Sato, Kenji Nakano, Makiko Ono, Junichi Tomomatsu, Hiroki Mitani, Shunji Takahashi
Publikováno v:
Endocrine. 76:70-77
The optimal timing for starting lenvatinib treatment in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC) has long been controversial because of the relatively slow-growing nature of differentiated thyroid cancer. The aim of
Publikováno v:
Cancers. 15:1473
Genotyping of tumor tissues to assess RAS and BRAF V600E mutations enables us to select optimal molecularly targeted therapies when considering treatment strategies for patients with metastatic colorectal cancer. Tissue-based genetic testing is limit
Autor:
Kenji Nakano, Naoki Fukuda, Yasuyoshi Sato, Tetsuya Urasaki, Akihiro Ohmoto, Xiaofei Wang, Naomi Hayashi, Hirotaka Suto, Shohei Udagawa, Ryosuke Oki, Mayu Yunokawa, Makiko Ono, Junichi Tomomatsu, Yusuke Minami, Keiko Hayakawa, Taisuke Tanizawa, Keisuke Ae, Seiichi Matsumoto, Shunji Takahashi
Publikováno v:
Oncology. 100(4)
Background: The clinical benefit of systemic chemotherapy for recurrent/metastatic retroperitoneal/intra-abdominal soft tissue sarcoma (STS) compared to its benefits for other primary lesions has not been known or sufficiently evaluated. Methods and
Autor:
Maki Saihara, Akihiko Gotoh, Susumu Maki, Keitaro Fujiwara, Mitsuru Moriyama, Masahiro Okabe, Shohei Udagawa, Tsubasa Watanabe, Michio Sakurai, Yasuo Aota, Tomohisa Yokoyama
Publikováno v:
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics. 58(2)
Primary effusion lymphoma (PEL) is a large B-cell lymphoma that only proliferates proliferating effusion in the body cavity. It is associated with human herpesvirus 8 (HHV8).HHV8 negative effusion lymphoma, which is different from PEL in many ways, h
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(5)
A man in his 40s was diagnosed with CML. He and his partner expressed their desire to have a child. We recommended planning the pregnancy after the achievement of major molecular response and completion of TKI therapy because we could not promise com
Autor:
Hikari, Konuma, Yasuo, Aota, Shohei, Udagawa, Tadahiro, Honda, Yuko, Okuda, Tetsu, Iwai, Hiroki, Sujino, Maya, Takahashi, Naoyuki, Kitagawa, Akihiko, Gotoh
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(3)
A 81-year-old female was diagnosed with symptomatic multiple myeloma (MM; IgG κ type, DS: IIB, ISS: 2) in August 2017. Although treatment with lenalidomide and dexamethasone was started, she developed deep venous thrombosis in the lower extremities